These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25007361)

  • 61. Acyclovir in the management of herpes labialis.
    Yeo JM; Fiddian AP
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():95-103. PubMed ID: 6355056
    [TBL] [Abstract][Full Text] [Related]  

  • 62. n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study.
    Habbema L; De Boulle K; Roders GA; Katz DH
    Acta Derm Venereol; 1996 Nov; 76(6):479-81. PubMed ID: 8982417
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study.
    Amir J; Harel L; Smetana Z; Varsano I
    BMJ; 1997 Jun; 314(7097):1800-3. PubMed ID: 9224082
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protocol for a randomised controlled trial of 90% kanuka honey versus 5% aciclovir for the treatment of herpes simplex labialis in the community setting.
    Semprini A; Singer J; Shortt N; Braithwaite I; Beasley R;
    BMJ Open; 2017 Aug; 7(8):e017766. PubMed ID: 28775197
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Herpes labialis treatment with acyclovir 5% modified aqueous cream: a double-blind randomized trial.
    Raborn GW; McGaw WT; Grace M; Percy J; Samuels S
    Oral Surg Oral Med Oral Pathol; 1989 Jun; 67(6):676-9. PubMed ID: 2740091
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study.
    Raborn GW; McGaw WT; Grace M; Tyrrell LD; Samuels SM
    J Am Dent Assoc; 1987 Jul; 115(1):38-42. PubMed ID: 3301980
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis.
    Spruance SL
    J Med Virol; 1993; Suppl 1():27-32. PubMed ID: 8245889
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of a topical herbal and mineral formulation (Dynamiclear) for the treatment of herpes simplex labialis in the community setting: study protocol for a randomised, double-blind placebo-controlled trial.
    Armour M; Semprini A; Ee C; MacCullagh L; Shortt N
    BMJ Open; 2020 Jan; 10(1):e031876. PubMed ID: 31932389
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral acyclovir in prevention of herpes labialis. A randomized, double-blind, multi-centered clinical trial.
    Raborn GW; Martel AY; Grace MG; McGaw WT
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Jan; 85(1):55-9. PubMed ID: 9474615
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined herbal preparation for topical treatment of Herpes labialis.
    Saller R; Büechi S; Meyrat R; Schmidhauser C
    Forsch Komplementarmed Klass Naturheilkd; 2001 Dec; 8(6):373-82. PubMed ID: 11799306
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta-analysis.
    Chen F; Xu H; Liu J; Cui Y; Luo X; Zhou Y; Chen Q; Jiang L
    J Oral Pathol Med; 2017 Sep; 46(8):561-568. PubMed ID: 27935123
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections.
    Van Vloten WA; Swart RN; Pot F
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():89-93. PubMed ID: 6355055
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial.
    Semprini A; Singer J; Braithwaite I; Shortt N; Thayabaran D; McConnell M; Weatherall M; Beasley R
    BMJ Open; 2019 May; 9(5):e026201. PubMed ID: 31092654
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis.
    Horwitz E; Pisanty S; Czerninski R; Helser M; Eliav E; Touitou E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Jun; 87(6):700-5. PubMed ID: 10397661
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis.
    Kaminester LH; Pariser RJ; Pariser DM; Weiss JS; Shavin JS; Landsman L; Haines HG; Osborne DW
    J Am Acad Dermatol; 1999 Dec; 41(6):996-1001. PubMed ID: 10570387
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Pharma clinics. How I treat ... recurrent herpes labialis].
    Petit L; Braham C; Nikkels AF; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2002 Feb; 57(2):67-71. PubMed ID: 11942180
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Single-dose famciclovir for the treatment of herpes labialis.
    Hull C; Spruance S; Tyring S; Hamed K
    Curr Med Res Opin; 2006 Sep; 22(9):1699-702. PubMed ID: 16968573
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A pilot study of treatment of herpes labialis with 1072 nm narrow waveband light.
    Dougal G; Kelly P
    Clin Exp Dermatol; 2001 Mar; 26(2):149-54. PubMed ID: 11298104
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy of topical acyclovir cream in first and recurrent episodes of genital herpes.
    Kinghorn GR; Turner EB; Barton IG; Potter CW; Burke CA; Fiddian AP
    Antiviral Res; 1983 Dec; 3(5-6):291-301. PubMed ID: 6670855
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trial.
    Shafran SD; Sacks SL; Aoki FY; Tyrrell DL; Schlech WF; Mendelson J; Rosenthal D; Gill MJ; Bader RL; Chang I
    J Infect Dis; 1997 Jul; 176(1):78-83. PubMed ID: 9207352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.